Navigation Links
Pharmos Corporation Announces Receipt of Nasdaq Noncompliance Letter
Date:11/13/2008

g Phase 2b testing in IBS patients. Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033). The Company also has a proprietary technology platform focusing on discovery and development of synthetic cannabinoid compounds with a focus on CB2 receptor selective agonists. Various CB2-selective compounds from Pharmos' pipeline have completed preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and other disorders. Pharmos is also working to commercialize its proprietary NanoEmulsion drug delivery system, which is in clinical-stage development for topical application of analgesic and anti-inflammatory agents.

Safe Harbor Statement

Statements made in this press release related to the business outlook and future financial performance of Pharmos, to the prospective market penetration of its drug products, to the development and commercialization of its pipeline products and to its expectations in connection with any future event, condition, performance or other matter, are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause results to differ materially from those set forth in these statements. Additional economic, competitive, governmental, technological, marketing and other factors identified in Pharmos' filings with the Securities and Exchange Commission could affect such results.


'/>"/>
SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Pharmos Restructures Operations in Israel
2. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
3. Pharmos Corporation Reports 2008 Third Quarter Results
4. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
5. Brooke Franchise Corporation Announces Selected July Results
6. MedThink Communications Retained by NanoBio Corporation
7. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
8. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
9. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
10. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
11. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... Amada Senior Care, premier provider of non-medical in-home care and ... – their Mesa, Arizona location . Amada franchise partners Kris Patmos and Kimberly ... rights to the area after years of experience in the sales and healthcare industries. ...
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the ... lead a national chief nursing officer recruitment for Capital Health ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... firm B. E. Smith, Tri-City Medical Center in Oceanside, Calif., has ... proven record of leading organization-wide compliance adaptation efforts and growing a focus on ...
(Date:7/1/2015)... ... July 01, 2015 , ... Research published in the journal ... app to test eyesight was just as accurate as those from standard paper-based charts ... Tropical Medicine is responsible for the development of the test, which does not depend ...
(Date:7/1/2015)... ... July 01, 2015 , ... METTLER TOLEDO is pleased ... weighing pans, ML-T balances give operators the room they need to carry out ... estate makes ML-T balances a perfect choice for day-to-day weighing in nearly any ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Phoenix Area 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Capital Health Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:METTLER TOLEDO Launches Compact ML-T Balances: Larger Pan Offers Greater Weighing Flexibility in Tight Spaces 2
... who suffer from asthma, particularly women, may have an ... of 30 years, researchers studied almost 100,000 patients who ... the patients showed any signs of cancer at their ... year after asthma diagnosis until the last day of ...
... is no cure for stiff-person syndrome, a disease marked ... (GAD65), an enzyme involved in the production of a ... which is only mildly successful at controlling symptoms. While ... suspected that it may be an autoimmune disorder. ...
... derived a new gel to reduce the hair loss ... side effects of the treatment of cancer. The pharmaceutical ... contains a drug known as GW8510, helped to prevent ... researcher Stephen Davis said the gel completely prevented hair ...
... take hormone replacement therapy appear to restore their cognitive ... hormone replacement therapy (HRT) can protect against dementia// is ... failed to demonstrate benefit.A new report, from researchers, ... of over 1,000 women from different countries for a ...
... probably get more benefit from investing in gymnasium membership and ... researchers at the Cleavland University // it is better to ... a machine Exercise machines are often advertised in a misleading ... fit to your body, and you may need to learn ...
... recent study has found that early puberty and late menopause ... a common symptom of osteoporosis, or brittle bone disease.// Most ... can occur as a result. , ,Researchers in Norway ... as age when her periods start, age when she first ...
Cached Medicine News:
(Date:7/1/2015)... June 24, 2015 ... addition of the "Future Horizons and Growth ... Supplier Shares and Country Forecasts" report to ... Strategies in the European Blood Banking Market 2015 ... to help current suppliers and potential market entrants ...
(Date:7/1/2015)... Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI ... disease and neurologic disorders, announced today the results of ... the Company,s lead compound. Results from the study show ... significantly inhibit the activation of inflammatory proteins in the ... compound in a Phase 1 clinical trial under a ...
(Date:7/1/2015)...  BioPharmX Corporation (NYSE MKT: BPMX) today announced the ... 3,636,364 shares of its common stock at a price ... granted the underwriters a 30-day option to purchase up ... public offering price. In addition, Korea Investment ... agreed to purchase 1,081,081 shares of common stock from ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3
... March 22 Royal Philips Electronics ( PHG, ... medical alert service.  This integrated solution offers an added ... medical alert service with automatic fall detection capabilities. Lifeline ... can automatically call for help if a fall is ...
... WALTHAM, Mass. , March 22 Interleukin Genetics, Inc. ... of the NYSE Amex LLC (the "Exchange") has granted the Company an ... Company will remain listed up to June 23, 2010 , subject ... progress towards the Company,s plan to regain compliance. , ...
Cached Medicine Technology:Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 2Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 3Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 4Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 5Philips Introduces Breakthrough Medical Alert Service That Helps Enable Continued Independence for Seniors by Improving Access to Help in the Event of a Fall 6NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 2NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards 3
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
3.5 mm blade. Round handle. Designated most popular model or size....
2 mm wide x 3 mm long, tapered handle. Angled 45 degrees. Round handle....
3 mm diameter roller blade, 15 mm from angle to tip. Round handle....
Medicine Products: